Re: "Gadolinium Deposition Disease: A New Risk Management Threat"

J Am Coll Radiol. 2020 Sep;17(9):1077-1078. doi: 10.1016/j.jacr.2020.06.016. Epub 2020 Jul 11.

Authors

Chia-Ying Liu¹, Laura Schöckel¹, Pamela Habib², Thomas Balzer¹, Hubertus Pietsch³

Affiliations

¹ US Medical Affairs, Bayer HealthCare, Whippany, New Jersey.
² US Medical Affairs Bayer HealthCare 100 Bayer Boulevard Whippany, NJ 07981-0915. Electronic address: [email protected].
³ Head of the Department of MR and CT Contrast Media Research, Bayer, Berlin, Germany.

PMID: 32663450
DOI: 10.1016/j.jacr.2020.06.016

No abstract available

Publication types

Letter
Comment

MeSH terms

Contrast Media*
Gadolinium*
Magnetic Resonance Imaging
Risk Management

Substances

Contrast Media
Gadolinium